The phenomenon of monkeypox, to which the chosen article is devoted, is insufficiently studied and attracts the attention of modern epidemiologists. At the moment, this disease and its spread have already been officially declared an epidemiological problem of a global scale, due to compliance with a number of global criteria. There are already 16,000 cases in 75 countries at the time of publication of the article, with a particularly high risk in Europe (Carstens, 2022). The article tries to create a compendium of information on this disease, which was spreading unnoticed until recently, and for this purpose it enlists the specialist Anne Rimoine, who has previously studied other smallpox. The disease is described by her as waiting for her surge, characteristic of other smallpox, while the scale of the incidence is shown as unpredictable.
As the first requirement to prevent the spread of the disease, the search for human mechanisms of smallpox transmission and the determination of periods of the highest contagiousness of an already sick carrier of the disease are called. The second requirement for doctors is to create a clinical picture of the disease for different ages and population groups. This article demonstrates that the emergence of new diseases is always a burden on the scientific and medical apparatus, challenging the medical system (Saxena, 2020). Cases of monkeypox in the context of the recent widespread spread of COVID-19 are of particular concern to doctors. The worry that it will be too hard for humanity to survive another epidemic all at once is the framework for the monkeypox narrative. The treatment of this disease as a potentially dangerous virus is naturally arising from the situation of the still unfinished pandemic and speaks of the increased responsibility of epidemiologists in the modern world.
References
Carstens, A. (2022). Monkeypox: What we know (and what we don’t). The Scientist. Web.
Saxena, S. K. (2020). Coronavirus disease 2019 Covid-19: Epidemiology, Pathogenesis, Diagnosis, and Therapeutics. Springer Nature.